Creative Medical Technology Stock Today
| CELZ Stock | USD 2.88 0.10 3.60% |
PerformanceOK
| Odds Of DistressHigh
|
Creative Medical is trading at 2.88 as of the 23rd of March 2025; that is 3.60 percent increase since the beginning of the trading day. The stock's open price was 2.78. Creative Medical has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 6th of November 2015 | Category Healthcare | Classification Health Care |
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona. Creative Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 2.32 M outstanding shares of which 98.25 K shares are currently shorted by private and institutional investors with about 1.4 trading days to cover. More on Creative Medical Technology
Moving against Creative Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Creative Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President CEO, Director | Timothy Warbington | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsCreative Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Creative Medical's financial leverage. It provides some insight into what part of Creative Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Creative Medical Technology (CELZ) is traded on NASDAQ Exchange in USA. It is located in 211 East Osborn Road, Phoenix, AZ, United States, 85012 and employs 4 people. Creative Medical is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.69 M. Creative Medical Tec conducts business under Biotechnology sector and is part of Health Care industry. The entity has 2.32 M outstanding shares of which 98.25 K shares are currently shorted by private and institutional investors with about 1.4 trading days to cover.
Creative Medical Technology currently holds about 22.86 M in cash with (5.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.62.
Check Creative Medical Probability Of Bankruptcy
Ownership AllocationAlmost 97.43 percent of Creative Medical outstanding shares are held by general public with 1.39 (percent) owned by insiders and only 1.18 % by other corporate entities.
Check Creative Ownership Details
Creative Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Vanguard Group Inc | 2024-12-31 | 17.6 K | |
| Geode Capital Management, Llc | 2024-12-31 | 10.3 K | |
| Tower Research Capital Llc | 2024-12-31 | 1.6 K | |
| Advisor Group Holdings, Inc. | 2024-12-31 | 131 | |
| Bank Of America Corp | 2024-12-31 | 122 | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 20.0 | |
| Td Waterhouse Canada Inc | 2024-12-31 | 1.0 | |
| Ubs Group Ag | 2024-12-31 | 1.0 | |
| Aaron Wealth Advisors Llc | 2024-12-31 | 0.0 | |
| Two Sigma Investments Llc | 2024-12-31 | 0.0 | |
| Two Sigma Advisers, Llc | 2024-12-31 | 0.0 |
Creative Medical Historical Income Statement
Creative Stock Against Markets
Creative Medical Corporate Executives
Elected by the shareholders, the Creative Medical's board of directors comprises two types of representatives: Creative Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Creative. The board's role is to monitor Creative Medical's management team and ensure that shareholders' interests are well served. Creative Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Creative Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Donald MBA | CFO VP | Profile |
Additional Tools for Creative Stock Analysis
When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.